Periodic Reporting for period 1 - MITI 2 (Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2))

Inflammatory Bowel Disease (IBD) is a disabling condition that causes many life-altering symptoms including life-threatening complications with a great medical need. The main objective of the MITI2 project is to deliver an immunotherapy product ready to be used in a phase 1...